Omnicom Group Inc/ US6819191064 /
30/05/2024 21:59:56 | Var. -0.38 | Volume | Denaro- | Lettera- | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
90.72USD | -0.42% | 49,660 Fatturato: 4.51 mill. |
-Quantità in denaro: - | -Quantità in lettera: - | 17.77 bill.USD | 3.09% | 13.00 |
GlobeNewswire
08:14
STMicroelectronics to build the world’s first fully integrated silicon carbide facility in Italy
GlobeNewswire
08:00
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
GlobeNewswire
07:30
Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
GlobeNewswire
07:05
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
07:05
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire
07:00
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire
07:00
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire
07:00
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
06:08
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
GlobeNewswire
05:00
Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options